Skip to content
Docusate sodium
Docusate sodium is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
docusate sodiumOTC monograph not final2023-06-21
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
constipationHP_0002019D003248K59.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A06: Drugs for constipation
A06A: Drugs for constipation
A06AA: Softeners, emollients
A06AA02: Docusate sodium
A06AG: Enema for constipation
A06AG10: Docusate sodium, incl. combinations
HCPCS
No data
Clinical
Clinical Trials
26 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ConstipationD003248HP_0002019K59.022519
DiarrheaD003967HP_0002014R19.71113
InfectionsD007239EFO_000054422
IleusD045823K56.7112
AnalgesiaD00069811
Morbid obesityD009767EFO_000107411
FlatulenceD005414R14.311
Covid-19D000086382U07.111
Clostridium infectionsD003015EFO_1000874A05.211
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.911
DyspneaD004417HP_0002094R06.011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.911
GastroparesisD018589EFO_1000948K31.8411
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients11
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Palliative careD01016611
Iron deficienciesD000090463E61.111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDOCUSATE SODIUM
INNdocusate sodium
Description
Sodium docusate is an organic sodium salt.
Classification
Small molecule
Drug classStool softener
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+]
Identifiers
PDB
CAS-ID577-11-7
RxCUI71722
ChEMBL IDCHEMBL1905872
ChEBI ID
PubChem CID23673837
DrugBankDB11089
UNII IDF05Q2T2JA0 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 537 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
917 adverse events reported
View more details